Inhibitory effect of troglitazone on TNF-α-induced expression of monocyte chemoattractant protein-1 (MCP-1) in human endothelial cells
- 1 June 2000
- journal article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 48 (3), 171-176
- https://doi.org/10.1016/s0168-8227(00)00128-5
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Thiazolidinediones Suppress Endothelin-1 Secretion from Bovine Vascular Endothelial Cells: A New Possible Role of PPARγ on Vascular Endothelial FunctionBiochemical and Biophysical Research Communications, 1999
- Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.Journal of Clinical Investigation, 1998
- Cytokine induction of monocyte chemoattractant protein‐1 gene expression in human endothelial cells depends on the cooperative action of NF‐χB and AP‐1European Journal of Immunology, 1997
- Inhibition of oxidation of low density lipoprotein by troglitazoneAtherosclerosis, 1996
- IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin ResistanceScience, 1996
- Cellular events in the evolution of experimental diabetic nephropathyKidney International, 1995
- Monocyte chemotactic protein gene expression by cytokine-treated human fibroblasts and endothelial cellsBiochemical and Biophysical Research Communications, 1989
- Human monocyte chemoattractant protein‐1 (MCP‐1) Full‐length cDNA cloning, expression in mitogen‐stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JEFEBS Letters, 1989
- Banting lecture 1988. Role of insulin resistance in human diseaseDiabetes, 1988
- Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in cultureBiochemistry, 1988